Indivior Pharmaceuticals (INDV) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $8.0 million.
- Indivior Pharmaceuticals' Accumulated Depreciation & Amortization fell 2727.27% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 2727.27%. This contributed to the annual value of $29.0 million for FY2024, which is 9333.33% up from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization is $8.0 million, which was down 2727.27% from $5.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $29.0 million in Q4 2024 and a low of $5.0 million during Q1 2024
- For the 5-year period, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $10.7 million, with its median value being $7.5 million (2024).
- As far as peak fluctuations go, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization surged by 16666.67% in 2022, and later tumbled by 2857.14% in 2025.
- Indivior Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $6.0 million in 2021, then skyrocketed by 166.67% to $16.0 million in 2022, then dropped by 6.25% to $15.0 million in 2023, then surged by 93.33% to $29.0 million in 2024, then tumbled by 72.41% to $8.0 million in 2025.
- Its last three reported values are $8.0 million in Q3 2025, $5.0 million for Q2 2025, and $5.0 million during Q1 2025.